Skip to content
healthcare.dev

HYRIMOZ

NDC 61314-454, adalimumab-adaz, injection, solution, from Sandoz Inc.

Product NDC
61314-454
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-454 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB80 mg/.8mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
61314-454-20613140454202 SYRINGE in 1 CARTON (61314-454-20) / .8 mL in 1 SYRINGE
61314-454-36613140454363 SYRINGE in 1 CARTON (61314-454-36) / .8 mL in 1 SYRINGE
61314-454-68613140454683 SYRINGE, GLASS in 1 CARTON (61314-454-68) / .8 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

Use it

Look up 61314-454 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-454 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-454. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.